Multiple Dose Trial Examining Dose Range, Escalation and Efficacy of Oral Semaglutide in Subjects With Type 2 Diabetes
Public ClinicalTrials.gov record NCT01923181. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This trial is conducted globally. The aim of the trial is to examine the dose range, escalation and efficacy of oral semaglutide in subjects with type 2 diabetes.
Study identification
- NCT ID
- NCT01923181
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 632 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 2, 2013 (Actual)
- Primary completion
- Dec 11, 2014 (Actual)
- Completion
- Dec 11, 2014 (Actual)
- Last update posted
- Jan 15, 2021
2013 – 2014
United States locations
- U.S. sites
- 40
- U.S. states
- 19
- U.S. cities
- 37
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Novo Nordisk Investigational Site | Tucson | Arizona | 85712 | — |
| Novo Nordisk Investigational Site | Chula Vista | California | 91911 | — |
| Novo Nordisk Investigational Site | Long Beach | California | 90806 | — |
| Novo Nordisk Investigational Site | Poway | California | 92064 | — |
| Novo Nordisk Investigational Site | Santa Ana | California | 92705 | — |
| Novo Nordisk Investigational Site | Spring Valley | California | 91978 | — |
| Novo Nordisk Investigational Site | Walnut Creek | California | 94598 | — |
| Novo Nordisk Investigational Site | Colorado Springs | Colorado | 80904 | — |
| Novo Nordisk Investigational Site | Denver | Colorado | 80220 | — |
| Novo Nordisk Investigational Site | Jacksonville | Florida | 32207 | — |
| Novo Nordisk Investigational Site | Miami | Florida | 33014 | — |
| Novo Nordisk Investigational Site | Plantation | Florida | 33324 | — |
| Novo Nordisk Investigational Site | South Miami | Florida | 33143 | — |
| Novo Nordisk Investigational Site | Athens | Georgia | 30606 | — |
| Novo Nordisk Investigational Site | Conyers | Georgia | 30094-5965 | — |
| Novo Nordisk Investigational Site | Addison | Illinois | 60101 | — |
| Novo Nordisk Investigational Site | Chicago | Illinois | 60634 | — |
| Novo Nordisk Investigational Site | Wichita | Kansas | 67205 | — |
| Novo Nordisk Investigational Site | Rockville | Maryland | 20852 | — |
| Novo Nordisk Investigational Site | Las Vegas | Nevada | 89103 | — |
| Novo Nordisk Investigational Site | Las Vegas | Nevada | 89109 | — |
| Novo Nordisk Investigational Site | New York | New York | 10001 | — |
| Novo Nordisk Investigational Site | New York | New York | 10032 | — |
| Novo Nordisk Investigational Site | Rochester | New York | 14609 | — |
| Novo Nordisk Investigational Site | Asheville | North Carolina | 28801 | — |
| Novo Nordisk Investigational Site | Raleigh | North Carolina | 27609 | — |
| Novo Nordisk Investigational Site | Salisbury | North Carolina | 28144 | — |
| Novo Nordisk Investigational Site | Fargo | North Dakota | 58104 | — |
| Novo Nordisk Investigational Site | Norman | Oklahoma | 73069 | — |
| Novo Nordisk Investigational Site | Jersey Shore | Pennsylvania | 17740 | — |
| Novo Nordisk Investigational Site | Philadelphia | Pennsylvania | 19140 | — |
| Novo Nordisk Investigational Site | Philadelphia | Pennsylvania | 19147 | — |
| Novo Nordisk Investigational Site | Moncks Corner | South Carolina | 29461 | — |
| Novo Nordisk Investigational Site | Humboldt | Tennessee | 38343 | — |
| Novo Nordisk Investigational Site | Spring Hill | Tennessee | 37174 | — |
| Novo Nordisk Investigational Site | Dallas | Texas | 75230 | — |
| Novo Nordisk Investigational Site | San Antonio | Texas | 78209 | — |
| Novo Nordisk Investigational Site | Sugar Land | Texas | 77478 | — |
| Novo Nordisk Investigational Site | Newport News | Virginia | 23606 | — |
| Novo Nordisk Investigational Site | Wenatchee | Washington | 98801-2028 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 63 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01923181, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jan 15, 2021 · Synced Sep 30, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT01923181 live on ClinicalTrials.gov.